Login / Signup

A response to Al et al. Trials 2023;24:233.

Jon F Merz
Published in: Trials (2023)
In their recent paper, Al and colleagues (Trials 2023;24:233) argue that manipulation of the methods of recruitment using well-known techniques in order to increase enrollment can be ethically acceptable. This brief response challenges that notion as an affront to voluntariness and a devolution of the ethics of human subjects research to the "ethics" of the marketplace.
Keyphrases
  • public health
  • big data
  • endothelial cells
  • affordable care act
  • global health
  • health insurance
  • machine learning
  • artificial intelligence